$33.8
Currently 20 wall-street analysts regularly analyze the financials of Crinetics Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 20 analysts offering 12-month price forecasts for Crinetics Pharmaceuticals Inc (CRNX) have a share price target of $70. This median of share price forecast represents a 107.1% upside from the latest price of $33.8 as on 17.09.25.
As per the chart shown above, analysts believe that the Crinetics Pharmaceuticals Inc (CRNX) share price will touch around $70 in next 12-months.
Below is a chart showing the percentage difference between Crinetics Pharmaceuticals Inc's share price and its median forecast price. As on 17.09.25, the difference is -59.87%
Based on 20 analysts tracking and researching Crinetics Pharmaceuticals Inc (CRNX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 12 | 12 | 12 |
Outperform | 5 | 6 | 6 |
Hold | 2 | 2 | 2 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |